| scholarly article | Q13442814 |
| P50 | author | Susan W Barnett | Q89214866 |
| Marjorie Robert-Guroff | Q30651738 | ||
| Thorsten Demberg | Q30651752 | ||
| Iskra Tuero | Q30651764 | ||
| David C. Montefiori | Q63302725 | ||
| Celia C LaBranche | Q63422835 | ||
| Mangala Rao | Q88258287 | ||
| P2093 | author name string | V S Kalyanaraman | |
| David Venzon | |||
| Diego A Vargas-Inchaustegui | |||
| Genoveffa Franchini | |||
| Maria Grazia Ferrari | |||
| Venkatramanan Mohanram | |||
| Ranajit Pal | |||
| Irene Kalisz | |||
| Monica Vaccari | |||
| Thomas Musich | |||
| Leia Miller | |||
| P2860 | cites work | Sex hormones selectively impact the endocervical mucosal microenvironment: implications for HIV transmission | Q21090622 |
| The use of nonhuman primate models in HIV vaccine development | Q21563403 | ||
| Estrogen receptors regulate an inflammatory pathway of dendritic cell differentiation: mechanisms and implications for immunity | Q26863531 | ||
| Vaccination against heterologous R5 clade C SHIV: prevention of infection and correlates of protection | Q27332360 | ||
| Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications | Q28185515 | ||
| Retracted: Comparative Immunogenicity of HIV-1 gp160, gp140 and gp120 Expressed by Live Attenuated Newcastle Disease Virus Vector | Q28533970 | ||
| Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand | Q29547531 | ||
| Fcgamma receptors as regulators of immune responses | Q29615584 | ||
| Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes | Q29616210 | ||
| Immune-correlates analysis of an HIV-1 vaccine efficacy trial | Q29617377 | ||
| High titer and avidity of nonneutralizing antibodies against influenza vaccine antigen are associated with severe influenza. | Q30416598 | ||
| A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples | Q30498394 | ||
| Antibodies with high avidity to the gp120 envelope protein in protection from simian immunodeficiency virus SIV(mac251) acquisition in an immunization regimen that mimics the RV-144 Thai trial | Q30532861 | ||
| T-cell correlates of vaccine efficacy after a heterologous simian immunodeficiency virus challenge | Q33826671 | ||
| Phenotypes and distribution of mucosal memory B-cell populations in the SIV/SHIV rhesus macaque model | Q33862010 | ||
| The role of sex hormones and the tissue environment in immune protection against HIV in the female reproductive tract | Q33934044 | ||
| Multiple vaccine-elicited nonneutralizing antienvelope antibody activities contribute to protective efficacy by reducing both acute and chronic viremia following simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques | Q33966586 | ||
| Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination | Q33977866 | ||
| Sex influences immune responses to viruses, and efficacy of prophylaxis and treatments for viral diseases | Q33997400 | ||
| Sex-based differences in HIV type 1 pathogenesis | Q34148475 | ||
| Human IgG Fc-glycosylation profiling reveals associations with age, sex, female sex hormones and thyroid cancer | Q34172346 | ||
| Improved flow-based method for HIV/SIV envelope-specific memory B-cell evaluation in rhesus macaques | Q34345369 | ||
| Antibody B cell responses in HIV-1 infection | Q38252874 | ||
| IgG subclass-independent improvement of antibody-dependent cellular cytotoxicity by fucose removal from Asn297-linked oligosaccharides | Q38320052 | ||
| Fucose depletion from human IgG1 oligosaccharide enhances binding enthalpy and association rate between IgG1 and FcgammaRIIIa | Q38343329 | ||
| Differential binding of neutralizing and non-neutralizing antibodies to native-like soluble HIV-1 Env trimers, uncleaved Env proteins, and monomeric subunits | Q38989507 | ||
| Comparative evaluation of trimeric envelope glycoproteins derived from subtype C and B HIV-1 R5 isolates | Q39484948 | ||
| Estrogen receptor-β signaling modulates epithelial barrier function | Q39605059 | ||
| Fc-glycosylation influences Fcγ receptor binding and cell-mediated anti-HIV activity of monoclonal antibody 2G12. | Q39637236 | ||
| Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays | Q39988991 | ||
| Fc receptor-mediated immune responses: new tools but increased complexity in HIV prevention | Q42257677 | ||
| Control of simian/human immunodeficiency virus viremia and disease progression after IL-2-augmented DNA-modified vaccinia virus Ankara nasal vaccination in nonhuman primates | Q43529311 | ||
| The strength of B cell immunity in female rhesus macaques is controlled by CD8+ T cells under the influence of ovarian steroid hormones | Q43975326 | ||
| Molecular methods for evaluation of virological status of nonhuman primates challenged with simian immunodeficiency or simian-human immunodeficiency viruses. | Q44065795 | ||
| Sex differences in HIV-1 viral load and progression to AIDS. | Q44567818 | ||
| Quantitative evaluation of simian immunodeficiency virus infection using NASBA technology | Q45743923 | ||
| High susceptibility to repeated, low-dose, vaginal SHIV exposure late in the luteal phase of the menstrual cycle of pigtail macaques. | Q46034053 | ||
| The effect of female sexual hormones on the intestinal and serum cytokine response after traumatic brain injury: different roles for estrogen receptor subtypes | Q47681880 | ||
| Immunogen design for HIV-1 and influenza. | Q51846035 | ||
| Nasal DNA-MVA SIV vaccination provides more significant protection from progression to AIDS than a similar intramuscular vaccination. | Q51890555 | ||
| Vaccine-induced CD8+ central memory T cells in protection from simian AIDS. | Q51989035 | ||
| A simplified method for the rapid fluorometric assessment of antibody-dependent cell-mediated cytotoxicity. | Q52841139 | ||
| Estrogen modulates intestinal mucus physiochemical properties and protects against oxidant injury. | Q53659585 | ||
| Immunization with HIV-1 gp41 Subunit Virosomes Induces Mucosal Antibodies Protecting Nonhuman Primates against Vaginal SHIV Challenges | Q59661537 | ||
| Durable protection of rhesus macaques immunized with a replicating adenovirus-SIV multigene prime/protein boost vaccine regimen against a second SIVmac251 rectal challenge: role of SIV-specific CD8+ T cell responses | Q64377680 | ||
| Lessons from the RV144 Thai phase III HIV-1 vaccine trial and the search for correlates of protection | Q34444625 | ||
| Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface | Q34473958 | ||
| Role of estrogen receptor beta in colonic epithelium | Q34479909 | ||
| Rapid SIV Env-specific mucosal and serum antibody induction augments cellular immunity in protecting immunized, elite-controller macaques against high dose heterologous SIV challenge | Q34574409 | ||
| Microbiome in human immunodeficiency virus infection | Q34626014 | ||
| Differential Roles of Estrogen Receptors α and β in Control of B-Cell Maturation and Selection | Q34699508 | ||
| Vaccine-elicited SIV and HIV envelope-specific IgA and IgG memory B cells in rhesus macaque peripheral blood correlate with functional antibody responses and reduced viremia | Q34810713 | ||
| Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine | Q35009558 | ||
| Structure and immune recognition of trimeric pre-fusion HIV-1 Env. | Q35142291 | ||
| HIV-1 sexual transmission: early events of HIV-1 infection of human cervico-vaginal tissue in an optimized ex vivo model. | Q35215387 | ||
| The microbiome in infectious disease and inflammation | Q35591962 | ||
| Identification of antibody glycosylation structures that predict monoclonal antibody Fc-effector function | Q35600028 | ||
| Replicating adenovirus-simian immunodeficiency virus (SIV) recombinant priming and envelope protein boosting elicits localized, mucosal IgA immunity in rhesus macaques correlated with delayed acquisition following a repeated low-dose rectal SIV(mac2 | Q35867976 | ||
| Replicating adenovirus-simian immunodeficiency virus (SIV) vectors efficiently prime SIV-specific systemic and mucosal immune responses by targeting myeloid dendritic cells and persisting in rectal macrophages, regardless of immunization route | Q35940685 | ||
| Magnitude and breadth of the neutralizing antibody response in the RV144 and Vax003 HIV-1 vaccine efficacy trials | Q36083337 | ||
| HIV-1 envelope trimer elicits more potent neutralizing antibody responses than monomeric gp120. | Q36132728 | ||
| Gag-specific cellular immunity determines in vitro viral inhibition and in vivo virologic control following simian immunodeficiency virus challenges of vaccinated rhesus monkeys | Q36246220 | ||
| Association of Fcγ receptor IIIa genotype with the rate of HIV infection after gp120 vaccination | Q36305326 | ||
| Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene family | Q36363231 | ||
| Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. | Q36368095 | ||
| Dynamics of memory B-cell populations in blood, lymph nodes, and bone marrow during antiretroviral therapy and envelope boosting in simian immunodeficiency virus SIVmac251-infected rhesus macaques | Q36397469 | ||
| The impact of glycosylation on the biological function and structure of human immunoglobulins. | Q36618276 | ||
| Cutting edge: novel vaccination modality provides significant protection against mucosal infection by highly pathogenic simian immunodeficiency virus | Q36674033 | ||
| Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity | Q36797342 | ||
| Sex differences matter in the gut: effect on mucosal immune activation and inflammation | Q36840134 | ||
| Protection against mucosal simian immunodeficiency virus SIV(mac251) challenge by using replicating adenovirus-SIV multigene vaccine priming and subunit boosting | Q36954239 | ||
| Human immunodeficiency virus type 1 env trimer immunization of macaques and impact of priming with viral vector or stabilized core protein. | Q37033291 | ||
| Comparison of systemic and mucosal vaccination: impact on intravenous and rectal SIV challenge | Q37067177 | ||
| Policy: NIH to balance sex in cell and animal studies | Q37403351 | ||
| Resistance to infection, early and persistent suppression of simian immunodeficiency virus SIVmac251 viremia, and significant reduction of tissue viral burden after mucosal vaccination in female rhesus macaques | Q37547763 | ||
| Novel female sex-dependent actions of oestrogen in the intestine. | Q37590546 | ||
| Sex affects immunity | Q37973808 | ||
| HIV vaccine research and discovery in the nonhuman primates model: a unified theory in acquisition prevention and control of SIV infection | Q38105946 | ||
| SeXX matters in immunity | Q38163200 | ||
| P275 | copyright license | Creative Commons CC0 License | Q6938433 |
| P6216 | copyright status | copyrighted, dedicated to the public domain by copyright holder | Q88088423 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e1005101 | |
| P577 | publication date | 2015-08-01 | |
| P1433 | published in | PLOS Pathogens | Q283209 |
| P1476 | title | Mucosal B Cells Are Associated with Delayed SIV Acquisition in Vaccinated Female but Not Male Rhesus Macaques Following SIVmac251 Rectal Challenge | |
| P478 | volume | 11 |
| Q47653590 | A Report of the 24th Annual Congress on Women's Health-Workshop on Transforming Women's Health: From Research to Practice |
| Q91638927 | ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type |
| Q40077472 | Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques |
| Q47319374 | An HSV-2 single-cycle candidate vaccine deleted in glycoprotein D, ΔgD-2, protects male mice from lethal skin challenge with clinical isolates of HSV-1 and HSV-2. |
| Q56517281 | Analysis of complement-mediated lysis of SIV and SIV-infected cells reveals sex differences in vaccine-induced immune responses in Rhesus macaques |
| Q54261850 | Associations of Simian Immunodeficiency Virus (SIV)-Specific Follicular CD8+ T Cells with Other Follicular T Cells Suggest Complex Contributions to SIV Viremia Control. |
| Q39481098 | B Cell Responses Associated with Vaccine-Induced Delayed SIVmac251 Acquisition in Female Rhesus Macaques |
| Q40587292 | Binding of estrogen receptors to switch sites and regulatory elements in the immunoglobulin heavy chain locus of activated B cells suggests a direct influence of estrogen on antibody expression. |
| Q37497214 | Biophysical and Functional Characterization of Rhesus Macaque IgG Subclasses. |
| Q92019600 | Current advances in HIV vaccine preclinical studies using Macaque models |
| Q64120873 | Early T Follicular Helper Cell Responses and Germinal Center Reactions Are Associated with Viremia Control in Immunized Rhesus Macaques |
| Q37409262 | Fc Receptor-Mediated Activities of Env-Specific Human Monoclonal Antibodies Generated from Volunteers Receiving the DNA Prime-Protein Boost HIV Vaccine DP6-001 |
| Q37347345 | HIV-1-Neutralizing IgA Detected in Genital Secretions of Highly HIV-1-Exposed Seronegative Women on Oral Preexposure Prophylaxis |
| Q40054979 | How germinal centers evolve broadly neutralizing antibodies: the breadth of the follicular helper T cell response. |
| Q39121590 | Influence of Plasma Cell Niche Factors on the Recruitment and Maintenance of IRF4hi Plasma Cells and Plasmablasts in Vaccinated, Simian Immunodeficiency Virus-Infected Rhesus Macaques with Low and High Viremia |
| Q33603602 | Mucosal Vaccination with Heterologous Viral Vectored Vaccine Targeting Subdominant SIV Accessory Antigens Strongly Inhibits Early Viral Replication. |
| Q39213726 | Mucosal and Systemic γδ+ T Cells Associated with Control of Simian Immunodeficiency Virus Infection. |
| Q38748193 | New developments in an old strategy: heterologous vector primes and envelope protein boosts in HIV vaccine design. |
| Q47139556 | Non-Neutralizing Antibodies Directed against HIV and Their Functions |
| Q41930380 | Phenotypic and Functional Characterization of Circulatory, Splenic, and Hepatic NK Cells in Simian Immunodeficiency Virus-Controlling Macaques. |
| Q51743315 | Reduced cell-associated DNA and improved viral control in macaques following passive transfer of a single anti-V2 monoclonal antibody and repeated SHIV challenges. |
| Q64118761 | Replicating Adenovirus-SIV Immunization of Rhesus Macaques Induces Mucosal Dendritic Cell Activation and Function Leading to Rectal Immune Responses |
| Q59351008 | Replication-competent NYVAC-KC yields improved immunogenicity to HIV-1 antigens in rhesus macaques, compared to non-replicating NYVAC |
| Q57454931 | The evolution of greater humoral immunity in females than males: implications for vaccine efficacy |
| Q98177674 | Topical Tenofovir Pre-exposure Prophylaxis and Mucosal HIV-Specific Fc-Mediated Antibody Activities in Women |
| Q92538999 | Update on Fc-Mediated Antibody Functions Against HIV-1 Beyond Neutralization |
| Q36553863 | Vaccine Induction of Lymph Node-Resident Simian Immunodeficiency Virus Env-Specific T Follicular Helper Cells in Rhesus Macaques |
| Q37253001 | Virus-Like Particles Displaying Trimeric Simian Immunodeficiency Virus (SIV) Envelope gp160 Enhance the Breadth of DNA/Modified Vaccinia Virus Ankara SIV Vaccine-Induced Antibody Responses in Rhesus Macaques |
| Q50034030 | Virus-Like-Vaccines against HIV. |
Search more.